Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor SuppressorJean‐Philippe Coppé|Unknown|2008Cited by 4.1k
Hyperphosphorylation of BCL-2 family proteins underlies functional resistance to venetoclax in lymphoid malignanciesStephen Jun Fei Chong, Matthew S. Davids, Yaw Chyn Lim et al.|Journal of Clinical Investigation|2023Cited by 43
Protein signaling and drug target activation signatures to guide therapy prioritization: Therapeutic resistance and sensitivity in the I-SPY 2 TrialRosa I. Gallagher, Emanuel F. Petricoin, Julia Wulfkuhle et al.|Cell Reports Medicine|2023Cited by 18
Predictive biomarkers of invasive carcinoma on excision in patients with a diagnosis of ductal carcinoma in situ of the breast by needle biopsy.Miki Mori, Laura van’t Veer, Gregor Krings et al.|Journal of Clinical Oncology|2014Cited by 0
A reversible SRC-relayed COX2-inflammatory program drives therapeutic resistance in BRAF <sup>V600E</sup> colorectal tumorsAna Ruiz-Sáenz, Jean‐Philippe Coppé|bioRxiv (Cold Spring Harbor Laboratory)|2022Cited by 0